Successful immunological treatment of gallbladder cancer in India–case report
/in Dendritic Cells, Gallbladder Cancer, International PublicationsImmunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers
/in Dendritic Cells, International Publications, Thyroid CancerImproved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
/in Dendritic Cells, International Publications, Malignant MelanomaHER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination
/in Breast Cancer, Dendritic Cells, International PublicationsVirology- and immunology-based gene therapy for cancer
/in Dendritic Cells, International PublicationsPure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination
/in Dendritic Cells, Hypernephroma, International Publications[Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma–a report of ten cases]
/in Dendritic Cells, Hypernephroma, International PublicationsA phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer